Tag: PEP
20
OctoberRaltegravir for Post-Exposure Prophylaxis: Is It a Viable Option?
Raltegravir is still used for HIV post-exposure prophylaxis, but dolutegravir is now preferred due to simpler dosing and better adherence. Learn when raltegravir remains the right choice.
Recent posts
-
31 Jan 2026
How to Properly Dispose of Expired Controlled Substances and Narcotics
-
21 Nov 2025
How to Check Drug Coverage Tiers and Formulary Changes for Medicare Part D
-
4 Feb 2026
Statins and Antifungal Medications: Rhabdomyolysis Risk Explained
-
21 Oct 2025
Cefuroxime and Alcohol: Risks, Side Effects, and Safe Guidelines
-
16 Oct 2025
How Betamethasone Treats Sarcoidosis: Dosage, Benefits, and Risks